Please use this identifier to cite or link to this item:
http://arks.princeton.edu/ark:/88435/dsp01gf06g536h| Title: | Transgender Athletes |
| Other Titles: | Therapeutic Use Exemption (TUE) PHYSICIAN GUIDELINES Medical Information to Support the Decisions of TUE Committees |
| Contributors: | World Anti-Doping Agency (WADA) |
| Keywords: | transgender athletes Therapeutic Use Exemption (TUE) transsexual female to male (FtM) male to female (MtF) gender-nonconforming transwomen, transmen |
| Issue Date: | Oct-2017 |
| Publisher: | World Anti-Doping Agency |
| Place of Publication: | Montreal, Canada |
| Description: | The exclusive purpose of this medical information is to define the criteria for granting a Therapeutic Use Exemption (TUE) for the treatment with substances on the Prohibited List to transgender athletes. It is not the purpose of this medical information to define the criteria for the eligibility of these athletes to participate in competitive sport, which is entirely left to the different sporting federations and organizations. |
| URI: | http://arks.princeton.edu/ark:/88435/dsp01gf06g536h |
| Related resource: | https://www.wada-ama.org/ |
| Appears in Collections: | Monographic reports and papers (Publicly Accessible) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| wada_transgender_athletes.pdf | 152.21 kB | Adobe PDF | View/Download |
Items in Dataspace are protected by copyright, with all rights reserved, unless otherwise indicated.